Lymphocyte subsets in bronchoalveolar lavage after exposure to Actinobacillus pleuropneumoniae in pigs previously immunized orally or by aerosol
- PMID: 7564482
- DOI: 10.1007/BF00181875
Lymphocyte subsets in bronchoalveolar lavage after exposure to Actinobacillus pleuropneumoniae in pigs previously immunized orally or by aerosol
Abstract
Young pigs were immunized with the lung-pathogenic bacterium Actinobacillus (Haemophilus) pleuropneumoniae by aerosol or orally using viable and inactivated bacteria. The cellular changes in the bronchoalveolar lavage (BAL) were studied in repeated lavages after the pigs were infected with live bacteria. The nucleated cells in the BAL were differentiated and lymphocyte subsets determined. There were no major differences between the two routes of immunization or between viable and inactivated bacteria. The immunization induced an increase in all lymphocyte subsets studied and in the appearance of plasma cells and lymphoid blasts. The infection did not cause a further increase except in granulocytes. The lack of a booster-type increase in lymphocytes in the BAL might indicate a different immunologic reaction of the lung or that lymphocytes of the BAL do not represent lung lymphocytes in general. The protective effect of the immunization might be deduced from the increase in lymphocytes after immunization but not from the reaction pattern after infection.
Similar articles
-
Pigs aerogenously immunized with genetically inactivated (ghosts) or irradiated Actinobacillus pleuropneumoniae are protected against a homologous aerosol challenge despite differing in pulmonary cellular and antibody responses.J Biotechnol. 1999 Aug 20;73(2-3):251-60. doi: 10.1016/s0168-1656(99)00143-1. J Biotechnol. 1999. PMID: 10486934
-
Immunization by the enteral and respiratory route with viable and inactivated bacteria results in a differential increase in lymphocyte subsets in the bronchoalveolar space.Adv Exp Med Biol. 1995;371B:1459-61. Adv Exp Med Biol. 1995. PMID: 7502837 No abstract available.
-
Oral immunization with lung-pathogenic bacteria is protective against defined challenge in a pig aerosol infection model.Adv Exp Med Biol. 1995;371B:803-6. Adv Exp Med Biol. 1995. PMID: 7502901 No abstract available.
-
Induction of protective immunity by aerosol or oral application of candidate vaccines in a dose-controlled pig aerosol infection model.J Biotechnol. 1996 Jan 26;44(1-3):171-81. doi: 10.1016/0168-1656(95)00150-6. J Biotechnol. 1996. PMID: 8717401 Review.
-
New trends in innovative vaccine development against Actinobacillus pleuropneumoniae.Vet Microbiol. 2018 Apr;217:66-75. doi: 10.1016/j.vetmic.2018.02.028. Epub 2018 Mar 6. Vet Microbiol. 2018. PMID: 29615259 Review.
Cited by
-
Evidence for a common mucosal immune system in the pig.Mol Immunol. 2015 Jul;66(1):22-34. doi: 10.1016/j.molimm.2014.09.004. Epub 2014 Sep 18. Mol Immunol. 2015. PMID: 25242212 Free PMC article. Review.